Acro Biomedical CO., LTD. (ACBM) — 10-K Filings
All 10-K filings from Acro Biomedical CO., LTD.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
ACBM Remains Pre-Revenue, Eyes Capital for Biomedical Future
— Jul 24, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) reported no revenue for the fiscal year ended December 31, 2024, consistent with the prior year, indicating a pre-revenue or no -
ACBM Revenue Skyrockets 300,000% on Concentrated Customer Base
— Jul 18, 2025 Risk: high
ACRO BIOMEDICAL CO., LTD. (ACBM) reported a significant increase in revenue from contracts with customers, reaching $60,042,000 in 2023, up from $20,000 in 2022
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX